1. Higher 25‐hydroxyvitamin D levels are associated with greater odds of remission with anti‐tumour necrosis factor‐α medications among patients with inflammatory bowel diseases. Issue 5 (10th January 2017) Authors: Winter, R. W.; Collins, E.; Cao, B.; Carrellas, M.; Crowell, A. M.; Korzenik, J. R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 5(2017) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗